Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile”

389 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 389 results

Large-scale testing (Phase 3)Looking for participantsNCT07282665
What this trial is testing

Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

Who this might be right for
Clostridioides Difficile Associated Disease
Pfizer 32,000
Not applicableLooking for participantsNCT06703918
What this trial is testing

Study on Clostridium Difficile Infection in Infants

Who this might be right for
Clostridium Difficile Infection
First People's Hospital of Hangzhou 150
Not applicableStudy completedNCT05447533
What this trial is testing

Clostridioides Difficile and Frailty

Who this might be right for
Frail ElderlyClostridioides DifficileGeriatric Assessment+2 more
University of Aarhus 217
Testing effectiveness (Phase 2)Study completedNCT02092935
What this trial is testing

SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)

Who this might be right for
Clostridium Difficile Infection
Summit Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Not applicableEnded earlyNCT01372943
What this trial is testing

Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Queen's University 4
Post-approval studies (Phase 4)UnknownNCT04415918
What this trial is testing

Bezlotoxumab Efficacy and Tolerability in Cancer Patient

Who this might be right for
Clostridium Difficile Infection Recurrence
The Cooper Health System 132
Testing effectiveness (Phase 2)Study completedNCT03589768
What this trial is testing

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

Who this might be right for
Clostridium Difficile ImmunisationDiphtheriaDiphtheria Immunisation+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 399
Post-approval studies (Phase 4)Ended earlyNCT04003818
What this trial is testing

Efficacy and Safety of Teicoplanin in CDAD

Who this might be right for
Clostridium Difficile Infection-associated Diarrhea and Colitis
Sanofi 50
Large-scale testing (Phase 3)Study completedNCT01597505
What this trial is testing

Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 606
Testing effectiveness (Phase 2)Study completedNCT05304715
What this trial is testing

Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile InfectionStool MicrobiomeOrgan Dysfunction Syndrome+2 more
Hellenic Institute for the Study of Sepsis 44
Testing effectiveness (Phase 2)Study completedNCT02561195
What this trial is testing

Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

Who this might be right for
Clostridium Difficile Associated Disease
Pfizer 300
Not applicableApproved For MarketingNCT02437500
What this trial is testing

Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI)

Who this might be right for
Clostridioides Difficile Infection
Seres Therapeutics, Inc.
Not applicableStudy completedNCT02063282
What this trial is testing

The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers

Who this might be right for
Clostridium DifficileColitis
Amos Yinnon 394
Not applicableNot Yet RecruitingNCT06702345
What this trial is testing

Clostridioides Difficile Controlled Human Infection Model

Who this might be right for
C. DifficileC. Difficile InfectionControlled Human Infection
Leiden University Medical Center 60
Not applicableEnded earlyNCT01533844
What this trial is testing

To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis

Who this might be right for
Clostridium Difficile
Astellas Pharma Europe B.V. 1
Testing effectiveness (Phase 2)Study completedNCT01896830
What this trial is testing

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan

Who this might be right for
Clostridium Difficile Infection
Sanofi Pasteur, a Sanofi Company 102
Post-approval studies (Phase 4)Study completedNCT02996487
What this trial is testing

Screening to Prophylax Against Clostridium Difficile Infection -

Who this might be right for
Clostridium Difficile Infection
Corewell Health East 1,294
Large-scale testing (Phase 3)Study completedNCT00106509
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisPseudomembranous Colitis
Genzyme, a Sanofi Company 520
Not applicableUnknownNCT04012788
What this trial is testing

CDI Synbiotic Study

Who this might be right for
Clostridium Difficile Infection
Hvidovre University Hospital 50
Load More Results